Mechanistic comparison of Ethynodiol Diacetate and Medroxyprogesterone Acetate based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
22
Shared Targets
47%
Jaccard Similarity
37%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Ethynodiol and Medroxyprogesterone share 22 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.468 means 47% of the combined target set is bound by both compounds. The IDF-weighted score of 0.374 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Ethynodiol and Medroxyprogesterone have in common?
Ethynodiol and Medroxyprogesterone share 22 molecular targets with a Jaccard similarity of 47%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Ethynodiol and Medroxyprogesterone be combined?
Ethynodiol and Medroxyprogesterone share 22 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Ethynodiol or Medroxyprogesterone?
Both Ethynodiol and Medroxyprogesterone have substantial PubMed research. View their individual profiles for full evidence scores.